IGF2 and nonpapillary renal cell carcinoma: As LOI research in ccRCC has been virtually completely limited to IGF2, here, we rely on the large-scale TCGA dataset to perform a genome-wide screen for LOI in ccRCC and to evaluate the clinical implications.